Besivance Suspension
Product Images NDC 24208-446

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Besivance (NDC 24208-446). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Besifloxacin Hydrochloride Structural Formula (964c5a85 3cc2 4d53 Ab7d F8d205d997e4 01)

Chemical structure of besifloxacin hydrochloride, the active ingredient in Besivance ophthalmic suspension 6 mg/mL by Bausch & Lomb Incorporated.*

FDA Label Image

Carton.jpg (Carton)

Packaging label for Besivance (besifloxacin ophthalmic suspension) 0.6% by Bausch & Lomb Incorporated. The label shows a 5 mL ophthalmic suspension with NDC 24208-446-05. It includes active and inactive ingredients, dosage instructions, storage information, and directions to invert and shake before use. The packaging emphasizes the product is Rx only and sterile, for topical ophthalmic use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.